These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Time course of ovarian tumour growth in soft agar culture. Verheijen RH; Feitz WF; Kenemans P; Vooys GP; Herman CJ Br J Cancer; 1985 Nov; 52(5):707-12. PubMed ID: 4063146 [TBL] [Abstract][Full Text] [Related]
43. The myelosuppressive effect of recombinant interferon gamma in short-term and long-term marrow cultures. Coutinho LH; Testa NG; Dexter TM Br J Haematol; 1986 Jul; 63(3):517-24. PubMed ID: 3089271 [TBL] [Abstract][Full Text] [Related]
44. In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow. Koyama S; Narita M Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1540-9. PubMed ID: 3150201 [No Abstract] [Full Text] [Related]
45. Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay. Aapro MS; Alberts DS; Salmon SE Cancer Chemother Pharmacol; 1983; 10(3):161-6. PubMed ID: 6861260 [TBL] [Abstract][Full Text] [Related]
46. Influence of interferon on antibody production and viability of malignant cells from patients with multiple myeloma. Grandér D; von Stedingk LV; von Stedingk M; Wasserman J; Einhorn S Eur J Haematol; 1991 Jan; 46(1):17-25. PubMed ID: 1703088 [TBL] [Abstract][Full Text] [Related]
47. Tumor growth stimulation in vitro by interferons. Ludwig CU; Durie BG; Salmon SE; Moon TE Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1625-32. PubMed ID: 6580172 [TBL] [Abstract][Full Text] [Related]
48. Growth of astrocytomas in the human tumor clonogenic assay and sensitivity to mismatched dsRNA and interferons. Strayer DR; Weisband J; Carter WA; Black P; Nidzgorski F; Cook AW Am J Clin Oncol; 1987 Aug; 10(4):281-4. PubMed ID: 3039828 [TBL] [Abstract][Full Text] [Related]
49. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay. Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222 [TBL] [Abstract][Full Text] [Related]
50. Human placental conditioned medium (from different phase of pregnancy) as a source of colony-stimulating activity for cultures of human and mouse. granulocyte-macrophage colony-forming cells in semisolid agar. Cinátl J; Lemez P; Hermanová E; Chudomel V; Neuwirtová R; Neuwirt J; Zivný J; Necas E Folia Biol (Praha); 1981; 27(3):186-93. PubMed ID: 6973492 [TBL] [Abstract][Full Text] [Related]
51. The effect of alpha and gamma-interferon on proliferation and production of IgE and beta 2-microglobulin in the human myeloma cell line U-266 and in an alpha-interferon resistant U-266 subline. Brenning G; Jernberg H; Gidlund M; Sjöberg O; Nilsson K Scand J Haematol; 1986 Oct; 37(4):280-8. PubMed ID: 3097807 [TBL] [Abstract][Full Text] [Related]
52. Suppression of human granulocyte-macrophage colony formation in vitro by natural killer cells. Dickinson AM; Jacobs EA; Williamson IK; Reid MM; Proctor SJ Clin Immunol Immunopathol; 1988 Oct; 49(1):83-90. PubMed ID: 3261671 [TBL] [Abstract][Full Text] [Related]
53. [Complete remission in multiple myeloma with natural interferon-alpha (HLBI) and melphalan/prednisolone intermittent therapy]. Ito M; Nakagawa T; Imoto S; Isobe T; Nakao Y Rinsho Ketsueki; 1990 Jun; 31(6):847-52. PubMed ID: 2214176 [TBL] [Abstract][Full Text] [Related]
54. Interferons in the treatment of multiple myeloma. Cooper MR Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441 [TBL] [Abstract][Full Text] [Related]
55. Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatment Group. Peest D; Deicher H; Coldewey R; Leo R; Bartl R; Bartels H; Braun HJ; von Broen IM; Fischer JT; Gramatzki M Onkologie; 1990 Dec; 13(6):458-60. PubMed ID: 2092283 [TBL] [Abstract][Full Text] [Related]
56. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response. Geissler D; Gastl G; Aulitzky W; Tilg H; Gaggl S; Konwalinka G; Huber C Leuk Res; 1990; 14(7):629-36. PubMed ID: 2388474 [TBL] [Abstract][Full Text] [Related]
57. The use of interferon in the treatment of multiple myeloma. Costanzi JJ; Pollard RB Semin Oncol; 1987 Jun; 14(2 Suppl 2):24-8. PubMed ID: 3296211 [TBL] [Abstract][Full Text] [Related]
58. Effect of interferon on the in vitro synthesis of paraprotein by plasma cells in myeloma. McGinnes K; Penny R Acta Haematol; 1988; 79(2):72-6. PubMed ID: 3124475 [TBL] [Abstract][Full Text] [Related]
59. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay. Higashihara J; Saito T; Berens ME; Welander CE Cancer Chemother Pharmacol; 1988; 22(3):215-22. PubMed ID: 3136942 [TBL] [Abstract][Full Text] [Related]